Dose escalation with three-dimensional conformal radiotherapy for prostate cancer. Is more dose really better in high-risk patients treated with androgen deprivation? [electronic resource]
Producer: 20070109Description: 600-7 p. digitalISSN:- 0936-6555
- Aged
- Androgen Antagonists -- therapeutic use
- Antineoplastic Agents, Hormonal -- therapeutic use
- Chemotherapy, Adjuvant
- Disease-Free Survival
- Follow-Up Studies
- Humans
- Male
- Middle Aged
- Multivariate Analysis
- Neoplasm Staging
- Prostate-Specific Antigen -- blood
- Prostatic Neoplasms -- drug therapy
- Radiotherapy Dosage
- Radiotherapy, Conformal -- adverse effects
- Risk Factors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.